Home › NDC Lookup › RxCUI directory › RxCUI 2694991

Trospium chloride 20 MG / xanomeline 100 MG Oral Capsule [Cobenfy] — RxCUI 2694991

RxNorm drug concept · Semantic branded drug
RxCUI 2694991 Semantic branded drug · SBD ● Current RxNorm concept 5 FDA products 11 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2694991
Official nameTrospium chloride 20 MG / xanomeline 100 MG Oral Capsule [Cobenfy]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asCOBENFY 100 MG / 20 MG Oral Capsule; Cobenfy 100 MG / 20 MG (equivalent to xanomeline tartrate 153.3 MG / trospium 18.3 MG) Oral Capsule
FDA products mapped5
Package NDCs mapped11
Reported Medicaid activity (SDUD)35,066 prescriptions · 49 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Trospium: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Trospium works by calming the bladder muscle so it doesn't squeeze so often or urgently. In clinical trials, it helped reduce the number of times people needed to rush to the bathr...
  • What exactly does trospium do, and will it really help my bladder symptoms?
  • Yes — timing really matters with trospium. You need to take it on an empty stomach, at least one hour before you eat, with a full glass of water. A high-fat meal can cut the amount...
  • Does it matter when I take it or whether I eat first?
📖 Read our full Trospium guide →

🕸️ Concept Web — How Trospium chloride 20 MG / xanomeline 100 MG Oral... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Trospium chloride 20 MG / xanomeline 100 MG Oral Capsule [Cobenfy] RxCUI 2694991

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 4

    The active substance itself — no strength, form, or brand attached yet.

    • Trospium 236778
    • Xanomeline 2694828
    • Trospium / xanomeline 2694836
    • Trospium chloride 38891
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Cobenfy 2694844
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Trospium / xanomeline Oral Capsule 2694839
    • Trospium chloride / xanomeline Oral Capsule 2694842
    • Trospium / xanomeline Oral Product 2694837
    • Trospium / xanomeline Pill 2694838
    • Trospium chloride / xanomeline Oral Product 2694840
    • Trospium chloride / xanomeline Pill 2694841
    • Trospium / xanomeline Oral Capsule [Cobenfy] 2694848
    • Trospium chloride / xanomeline Oral Capsule [Cobenfy] 2694849
    • +5 more in this family
  4. Clinical & branded drugs 4

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

  5. Packs 4

    Fixed collections of drugs packaged and sold together, like dose packs.

Showing up to 8 concepts per family — 21 of 26 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

📦 FDA Products & Package NDCs

5 products · 11 package NDCs
11 package NDCs map to RxCUI 2694991 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00003-0050-14 14 CAPSULE, COATED PELLETS in 1 BLISTER PACK (0003-0050-14) Cobenfy E.R. Squibb & Sons, L.L.C. 2024-09-27
00003-0050-60 60 CAPSULE, COATED PELLETS in 1 BOTTLE (0003-0050-60) Cobenfy E.R. Squibb & Sons, L.L.C. 2024-09-27
00003-0050-98 10 BLISTER PACK in 1 CARTON (0003-0050-98) / 10 CAPSULE, CO... Cobenfy E.R. Squibb & Sons, L.L.C. 2026-06-15
00003-0125-14 14 CAPSULE, COATED PELLETS in 1 BLISTER PACK (0003-0125-14) Cobenfy E.R. Squibb & Sons, L.L.C. 2024-09-27
00003-0125-60 60 CAPSULE, COATED PELLETS in 1 BOTTLE (0003-0125-60) Cobenfy E.R. Squibb & Sons, L.L.C. 2024-09-27
00003-0125-98 10 BLISTER PACK in 1 CARTON (0003-0125-98) / 10 CAPSULE, CO... Cobenfy E.R. Squibb & Sons, L.L.C. 2026-06-15
00003-1100-14 14 CAPSULE, COATED PELLETS in 1 BLISTER PACK (0003-1100-14) Cobenfy E.R. Squibb & Sons, L.L.C. 2024-09-27
00003-1100-60 60 CAPSULE, COATED PELLETS in 1 BOTTLE (0003-1100-60) Cobenfy E.R. Squibb & Sons, L.L.C. 2024-09-27
00003-1100-98 10 BLISTER PACK in 1 CARTON (0003-1100-98) / 10 CAPSULE, CO... Cobenfy E.R. Squibb & Sons, L.L.C. 2026-06-15
00003-5150-14 1 KIT in 1 CARTON (0003-5150-14) * 1 BLISTER PACK in 1 PAC... Cobenfy E.R. Squibb & Sons, L.L.C. 2024-09-27
00003-5200-56 1 KIT in 1 CARTON (0003-5200-56) * 1 BLISTER PACK in 1 PAC... Cobenfy E.R. Squibb & Sons, L.L.C. 2024-09-27
Observed labelers: E.R. Squibb & Sons, L.L.C. (11) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.